Qure.ai expands executive team with Dr Javier J Zulueta chief medical officer, pulmonology to bolster cancer survival: Our ...

Altimmune, Inc., a late clinical-stage biopharmaceutical company developing peptide-based therapeutics for liver and cardiometabolic diseases, announced that the US Food and Drug Administration (FDA) ...

Thermo Fisher Scientific announces crucial investments in India at Biopharma Conclave 2025: Our Bureau, Bengaluru Thursday, August 21, 2025, 15:45 Hrs [IST] Thermo Fisher Scientif ...

Alcon India unveils UNITY VCS and UNITY CS with superior efficiency for vitreoretinal and cataract surgery: Our Bureau, Bengaluru Thursday, August 21, 2025, 14:40 Hrs [IST] Alcon, ...

Conshohocken, Pennsylvania Thursday, August 21, 2025, 14:00 Hrs [IST] ...

The Central Drugs Standard Control Organisation (CDSCO) has declared 143 drug samples tested by the Central and State drugs regulatory authorities in the month of July as Not of Standard Quality (NSQ) ...

Study shows restricted blood flow speeds tumour growth by aging immune system: New York Thursday, August 21, 2025, 15:00 Hrs [IST] According to a new study from NYU Langone Health ...

Our Bureau, Mumbai Wednesday, August 20, 2025, 17:15 Hrs [IST] ...

Silver Spring, Maryland Thursday, August 21, 2025, 13:00 Hrs [IST] ...

BioMed X & Novo Nordisk launch new collaboration in oral peptide drug delivery: Heidelberg, Germany Thursday, August 21, 2025, 12:00 Hrs [IST] BioMed X, an independent biomedical ...

Novo Nordisk’s Ozempic gets Health Canada approval to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with T2D & CKD: Mis ...

The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), has entered into a new agreement with GALVmed to develop and deploy a safer and more effective ...